Alan V Boddy (A V Boddy)

Years Active: 2018-2022
Publications (10 Years): 5

University of South Australia

University of Manchester (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of South Australia Jul 23 2018

Aruba

Head of School :: Pharmacy and Medical Sciences

University of Sydney Aug 01 2014 - Jul 22 2018

Australia

Professor (Cancer Therapeutics and Personalised Medicine) :: Pharmacy

Newcastle University Aug 01 2006 - Jul 31 2014

United Kingdom

Professor :: Northern Institution For Cancer Research

Education History

University of Manchester Sep 01 1983 - Aug 31 1986

United Kingdom

PHD :: Pharmacy

University of Manchester Sep 01 1979 - Jul 31 1982

United Kingdom

BSC :: Pharmacy

Publications

Jeffry Adiwidjaja, Alan V Boddy, Andrew J McLachlan
Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinib. European journal of clinical pharmacology 78 (4) (2022)
Jeffry Adiwidjaja, Josephine A Adattini, Alan V Boddy, Andrew J McLachlan
Physiologically Based Pharmacokinetic Modeling Approaches for Patients With SARS-CoV-2 Infection: A Case Study With Imatinib. Journal of clinical pharmacology 62 (10) (2022)
Jeffry Adiwidjaja, Annette S Gross, Alan V Boddy, Andrew J McLachlan
Physiologically-based pharmacokinetic model predictions of inter-ethnic differences in imatinib pharmacokinetics and dosing regimens. British journal of clinical pharmacology (2021)
Jeffry Adiwidjaja, Alan V Boddy, Andrew J McLachlan
Potential for pharmacokinetic interactions between Schisandra sphenanthera and bosutinib, but not imatinib: in vitro metabolism study combined with a physiologically-based pharmacokinetic modelling approach. British journal of clinical pharmacology 86 (10) (2020)
Janna K Duong, Gareth J Veal, C E Nath, P J Shaw, J Errington, R Ladenstein, Alan V Boddy
Population pharmacokinetics of carboplatin, etoposide and melphalan in children: a re-evaluation of paediatric dosing formulas for carboplatin in patients with normal or mild impairment of renal function. British journal of clinical pharmacology 85 (1) (2018)

Alan V Boddy.css-eqlu8i{font-size:small;padding-left:4px;} (A V Boddy)